Mutational landscape and potential therapeutic targets for sporadic pancreatic neuroendocrine tumors based on target next-generation sequencing.

Zheng, Kailian; Liu, Tao; Zhao, Jiangman; Meng, Peng; Bian, Yun; Ni, Chenming; Wang, Huan; Pan, Yaqi; Wu, Shouxin; Jiang, Hui; Jin, Gang.

Afiliação

Zheng K; Department of General Surgery, Shanghai Changhai Hospital, Naval Medical University, Shanghai 200433, P.R. China.
Liu T; Department of Emergency, Shanghai Changhai Hospital, Naval Medical University, Shanghai 200433, P.R. China.
Zhao J; Shanghai Zhangjiang Institute of Medical Innovation, Shanghai 201204, P.R. China.
Meng P; Shanghai Biotecan Pharmaceuticals Co., Ltd., Shanghai 201204, P.R. China.
Bian Y; Shanghai Zhangjiang Institute of Medical Innovation, Shanghai 201204, P.R. China.
Ni C; Shanghai Biotecan Pharmaceuticals Co., Ltd., Shanghai 201204, P.R. China.
Wang H; Department of Imaging, Shanghai Changhai Hospital, Naval Medical University, Shanghai 200433, P.R. China.
Pan Y; Department of General Surgery, Shanghai Changhai Hospital, Naval Medical University, Shanghai 200433, P.R. China.
Wu S; Department of General Surgery, Shanghai Changhai Hospital, Naval Medical University, Shanghai 200433, P.R. China.
Jiang H; Department of General Surgery, Shanghai Changhai Hospital, Naval Medical University, Shanghai 200433, P.R. China.
Jin G; Shanghai Zhangjiang Institute of Medical Innovation, Shanghai 201204, P.R. China.